For example, only TnT (biomarkers of damage to heart muscle) and NT-proBNP (bio-marker of heart failure) showed continuous increase post-treatment in sarcoma patients versus CRP (biomarker for inflammation) and TNFα (biomarker for heart failure) in breast cancer patients. This evidence concerns the gene CRP and breast carcinoma.